A Phase 2 interventional study of Educational Intervention and Questionnaire Administration in Melanoma, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-22.
Sponsored by Mayo Clinic · Phase 2, Interventional, and Prevention
This clinical trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms to increase the knowledge and practice of sun smart behaviors (sunscreen use, sun protective clothing use, self-skin examination) may help reduce risk of and incidence of melanoma and improve cancer survival.
PRIMARY OBJECTIVES:
I. Develop online education platform to educate the Hispanic community. II. Demonstrate improvement in knowledge and practice of sun smart behaviors. III. Determine if the education platform leads to increase visits to their medical provider and increase diagnosis of skin cancers, particularly melanoma, in our population.
OUTLINE:
Participants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.
3,006 studies on the registry are indexed under Melanoma; 520 are open to participants now.
This study's enrollment of 145 is above the median of 38 across 2,351 interventional studies indexed under Melanoma.
Browse Melanoma studies →Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.
Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants complete an educational training module and complete questionnaire at baseline (before educational training module) and 3 months after completing educational training.
Other: Educational Intervention · Other: Questionnaire Administration
Complete educational training module
Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Complete questionnaire
Knowledge score after completing the educational module
For quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The melanoma knowledge score will be a percent correct, between 0% and 100% (100% is the best score), on a participant questionnaire. The primary outcome is the change in participant melanoma knowledge score before and immediately after completing the melanoma education (the intervention in this study).
Time frame: Up to 3 months
Knowledge score three months after completing the educational module
For quantitative variables, descriptive statistics including number of observations, mean, median, standard deviation, and range will be given for the values. Qualitative variables will be summarized using counts and percentages. Associations between quantitative variables will be conducted using the Pearson linear correlation coefficient, and the Chi-squared or Fisher's exact test for categorical variables.The secondary outcome is their melanoma knowledge score at the three-month follow-up.
Time frame: 3 months after completing education module
This study is terminated, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mayo Clinic